Altamira Therapeutics Ltd. Administrative Expense
Altamira Therapeutics Ltd. (CYTOF) reported Administrative Expense of $2.15 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdministrativeExpense · last filed 2025-04-30
CHF
| Period end | Administrative Expense 12 month | Administrative Expense 12 month as first filed |
|---|---|---|
| 2023-12-31 | 2.27M CHF 20-F/A · filed 2024-04-22 | |
| 2022-12-31 | 2.52M CHF 20-F/A · filed 2024-04-22 | 2.67M CHF 20-F · filed 2023-05-16 |
| 2021-12-31 | 2.10M CHF 20-F/A · filed 2024-04-22 | 2.25M CHF 20-F · filed 2022-04-12 |
| 2020-12-31 | 1.65M CHF 20-F · filed 2023-05-16 | |
| 2019-12-31 | 2.65M CHF 20-F · filed 2022-04-12 | |
| 2018-12-31 | 2.80M CHF 20-F · filed 2021-03-31 | |
| 2017-12-31 | 2.52M CHF 20-F · filed 2020-04-16 | |
| 2016-12-31 | 2.97M CHF 20-F · filed 2019-03-14 | |
| 2015-12-31 | 2.39M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Administrative Expense 12 month |
|---|---|
| 2024-12-31 | $2.15M 20-F · filed 2025-04-30 |
| 2023-12-31 | $2.53M 20-F · filed 2025-04-30 |
| 2022-12-31 | $2.64M 20-F · filed 2025-04-30 |